Literature DB >> 18752290

Pair distribution function X-ray analysis explains dissolution characteristics of felodipine melt extrusion products.

K Nollenberger1, A Gryczke, Ch Meier, J Dressman, M U Schmidt, S Brühne.   

Abstract

Solid solutions of felodipine with EUDRAGIT E and EUDRAGIT E/NE were shown to dramatically increase the dissolution rate of felodipine in biorelevant media. Of the two polymer systems, extrudates containing 5% EUDRAGIT NE showed a faster dissolution rate and less recrystallization (no precipitation within 2 h). Although differential scanning calorimetry (DSC) and conventional X-ray powder diffraction (XRPD) were able to verify the amorphous state of the drug after melt extrusion, it was not possible to differentiate the two extrudate compositions further with these methods. We then applied pair distribution function (PDF) analysis to investigate extrudates. It was possible to more closely characterize the solid state of the amorphous extrudates in terms of local structural order: PDF analysis revealed that addition of minor amounts of EUDRAGIT NE to the main component EUDRAGIT E during extrusion changed the local structure of EUDRAGIT E in a nonadditive way. We conclude that local ordering can be important to the release characteristics of extrudates, even when the components are present in the amorphous state.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18752290     DOI: 10.1002/jps.21534

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Structural interpretation in composite systems using powder X-ray diffraction: applications of error propagation to the pair distribution function.

Authors:  Michael D Moore; Zhenqi Shi; Peter L D Wildfong
Journal:  Pharm Res       Date:  2010-09-02       Impact factor: 4.200

Review 2.  Structural Analysis of Molecular Materials Using the Pair Distribution Function.

Authors:  Maxwell W Terban; Simon J L Billinge
Journal:  Chem Rev       Date:  2021-11-17       Impact factor: 60.622

3.  Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions.

Authors:  Jiannan Lu; Kristina Cuellar; Nathan I Hammer; Seongbong Jo; Andreas Gryczke; Karl Kolter; Nigel Langley; Michael A Repka
Journal:  Drug Dev Ind Pharm       Date:  2015-11-04       Impact factor: 3.225

4.  Comparison and evaluation of pair distribution functions, using a similarity measure based on cross-correlation functions.

Authors:  Stefan Habermehl; Carina Schlesinger; Dragica Prill
Journal:  J Appl Crystallogr       Date:  2021-03-31       Impact factor: 4.868

5.  Local Structure of Ion Pair Interaction in Lapatinib Amorphous Dispersions characterized by Synchrotron X-Ray diffraction and Pair Distribution Function Analysis.

Authors:  Gabriel L B de Araujo; Chris J Benmore; Stephen R Byrn
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

Review 6.  Using X-ray Diffraction Techniques for Biomimetic Drug Development, Formulation, and Polymorphic Characterization.

Authors:  Israel Rodríguez; Ritika Gautam; Arthur D Tinoco
Journal:  Biomimetics (Basel)       Date:  2020-12-30

Review 7.  Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.

Authors:  Palpandi Pandi; Raviteja Bulusu; Nagavendra Kommineni; Wahid Khan; Mandip Singh
Journal:  Int J Pharm       Date:  2020-06-18       Impact factor: 5.875

8.  Rapid assessment of homogeneity and stability of amorphous solid dispersions by atomic force microscopy--from bench to batch.

Authors:  Matthias E Lauer; Monira Siam; Joseph Tardio; Susanne Page; Johannes H Kindt; Olaf Grassmann
Journal:  Pharm Res       Date:  2013-05-15       Impact factor: 4.200

9.  Atomic pairwise distribution function analysis of the amorphous phase prepared by different manufacturing routes.

Authors:  Johan P Boetker; Vishal Koradia; Thomas Rades; Jukka Rantanen; Marja Savolainen
Journal:  Pharmaceutics       Date:  2012-01-31       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.